Q1 2020 Holdings
Filed 2020-04-28 | 9 holdings | $364.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $177.2M | 4,205,615 | 48.6% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $69.1M | 7,068,233 | 18.9% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $58.0M | 2,736,572 | 15.9% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $29.3M | 1,205,407 | 8.0% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $18.1M | 3,102,929 | 5.0% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $11.0M | 2,215,384 | 3.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $804.8K | 543,753 | 0.2% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $647.8K | 101,855 | 0.2% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $558.6K | 561,612 | 0.2% |